162 related articles for article (PubMed ID: 8483427)
1. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy.
Smith P; Heimer G; Lindskog M; Ulmsten U
Maturitas; 1993 Mar; 16(2):145-54. PubMed ID: 8483427
[TBL] [Abstract][Full Text] [Related]
2. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
Smith P
Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
[TBL] [Abstract][Full Text] [Related]
3. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.
Ayton RA; Darling GM; Murkies AL; Farrell EA; Weisberg E; Selinus I; Fraser ID
Br J Obstet Gynaecol; 1996 Apr; 103(4):351-8. PubMed ID: 8605133
[TBL] [Abstract][Full Text] [Related]
5. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
7. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
[TBL] [Abstract][Full Text] [Related]
8. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging.
Henriksson L; Stjernquist M; Boquist L; Cedergren I; Selinus I
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):85-92. PubMed ID: 8572039
[TBL] [Abstract][Full Text] [Related]
9. Vaginal administration of low-dose oestradiol--effects on the endometrium and vaginal cytology.
Mattsson LA; Cullberg G; Eriksson O; Knutsson F
Maturitas; 1989 Sep; 11(3):217-22. PubMed ID: 2593865
[TBL] [Abstract][Full Text] [Related]
10. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group.
Casper F; Petri E
Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(3):171-6. PubMed ID: 10430010
[TBL] [Abstract][Full Text] [Related]
11. Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy.
Holmgren PA; Lindskog M; von Schoultz B
Maturitas; 1989 Mar; 11(1):55-63. PubMed ID: 2498619
[TBL] [Abstract][Full Text] [Related]
12. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
13. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study.
Nilsson K; Heimer G
Maturitas; 1992 Oct; 15(2):121-7. PubMed ID: 1470044
[TBL] [Abstract][Full Text] [Related]
14. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
15. Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.
Pinkerton JV; Shifren JL; La Valleur J; Rosen A; Roesinger M; Siddhanti S
Menopause; 2003; 10(1):45-52. PubMed ID: 12544676
[TBL] [Abstract][Full Text] [Related]
16. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms.
Lose G; Englev E
BJOG; 2000 Aug; 107(8):1029-34. PubMed ID: 10955437
[TBL] [Abstract][Full Text] [Related]
17. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms.
Manonai J; Theppisai U; Chittacharoen A
J Med Assoc Thai; 2001 Jul; 84(7):1015-20. PubMed ID: 11759960
[TBL] [Abstract][Full Text] [Related]
18. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
Casper F; Petri E; Benninghoff B
Zentralbl Gynakol; 1998; 120(9):449-53. PubMed ID: 9796090
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of the estradiol vaginal ring in the U.S.
Nachtigall LE
Maturitas; 1995 Dec; 22 Suppl():S43-7. PubMed ID: 8775777
[TBL] [Abstract][Full Text] [Related]
20. Treatment of urogenital atrophy with low-dose estradiol: preliminary results.
Santen RJ; Pinkerton JV; Conaway M; Ropka M; Wisniewski L; Demers L; Klein KO
Menopause; 2002; 9(3):179-87. PubMed ID: 11973441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
